Why the study?
While fibrinogen levels are a recognized risk factor for MI, the association of thrombotic risk with other coagulation proteins is inconsistent, likely due to the complex individual balance of pro- and anticoagulant factors.
Population
162 patients with MI at <50 y and 186 age- and gender-matched healthy controls
Comparison
Premature MI patients vs healthy controls with no CAD history
Design
Case-control study with mathematical modeling
Authors
Loading...
Coagulation imbalances may aid premature MI risk stratification; hypothesis-generating for prospective validation.
Mathematical modeling of the hemostatic proteome reveals distinct procoagulant profiles in patients with premature MI compared to healthy controls, highlighting potential new avenues for risk stratification.
Dunster et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: